2482. Impact of a Recombinant Zoster Vaccine on Quality of Life: Data from a Randomized, Placebo-Controlled, Phase 3 Trial in Adult Hematopoietic Stem Cell Transplant Recipients

BACKGROUND: Herpes zoster (HZ) and its complications can have a substantial impact on patients’ quality of life (QoL), particularly in immunocompromised patients. The vaccine efficacy (VE) of an adjuvanted recombinant zoster vaccine (RZV) was studied in a randomized, placebo-controlled, phase 3 stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Curran, Desmond, Anagnostopoulos, Achilles, Barista, Ibrahim, Bastidas, Adriana, Chandrasekar, Pranatharthi, Dickinson, Michael, Heras, Inmaculada, Idrissi, Mohamed El, Matthews, Sean, Milliken, Samuel, Coll, Jorge Monserrat, Matilla, Maria Belen Navarro, Oostvogels, Lidia, Quiel, Dimas, Rowley, Scott, Sabry, Waleed, Selleslag, Dominik, Szer, Jeff, Theunissen, Koen, Yegin, Zeynep Arzu, Yeh, Su-Peng, Young, Jo-Anne, Zaja, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253678/
http://dx.doi.org/10.1093/ofid/ofy210.2135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253678/
http://dx.doi.org/10.1093/ofid/ofy210.2135

Ejemplares similares